Not yet available for NY Residents
$95.00
Lyme Dot-Blot Assay (LDA) is a qualitative immunoassay for the direct detection of Borrelia burgdorferi-specific antigens in a patient cerebral spinal fluid (CSF) sample using anti-B. burgdorferi antibodies.
Purpose
The antigens present in the CSF sample are immobilized onto a membrane in a Dot-blot format and incubated with anti-B. burgdorferi-specific antibodies. After washing the bound anti-B. burgdorferi-specific antibodies, they are reacted with anti-rabbit IgG, which is visualized by an enzyme/substrate reaction.
Tube / Specimen Requirements
2mL CSF
CPT Code(s)
87449
Any Stage of Disease
Test MethodologyLDA
Available in New YorkNo
Not yet available for NY Residents
The first step in getting tested with IGeneX is to order a collection kit. Choose between a Blood, Urine, or Miscellaneous kit.
1.800.832.3200
For the most up to date and accurate information and articles about ticks and tick-borne diseases, please visit Tick Talk Resource.
Enter your email address to receive periodic marketing communications from IGeneX.